Who
Albert Luderer
Interim Chief Executive
Company insider
Files Form 4 as: Interim Chief Executive, Bionano Genomics.
In numbers
- Trades disclosed
- 14
- Buys
- 2
- Sells
- 0
- Bought
- $19K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Oct 2018
- Last trade
- 4 Sep 2026
- Last filed
- 9 Sep 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Sep 2026filed 9 Sep 2026 | BNGO Bionano GenomicsLife-science tools | SEC FORM 4 Bought | $4,8454,000 at $1.21 | filing |
| 4 Sep 2026filed 9 Sep 2026 | BNGO Bionano GenomicsLife-science tools | SEC FORM 4 Bought | $4,8404,000 at $1.21 | filing |
| 21 Aug 2026filed 21 Aug 2026 | BNGO Bionano GenomicsLife-science tools | SEC FORM 4 Bought | $4,8604,000 at $1.22 | filing |
| 21 Aug 2026filed 21 Aug 2026 | BNGO Bionano GenomicsLife-science tools | SEC FORM 4 Bought | $4,8804,000 at $1.22 | filing |
| 11 Jun 2025filed 12 Jun 2025 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —2,775 at $0.00 | filing |
| 18 Jun 2024filed 20 Jun 2024 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 9 Jun 2022filed 13 Jun 2022 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —164,422 at $0.00 | filing |
| 17 Aug 2021filed 19 Aug 2021 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —40,751 at $0.00 | filing |
| 10 Jun 2021filed 14 Jun 2021 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —7,528 at $0.00 | filing |
| 30 Jun 2020filed 18 Jul 2022 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —44,470 at $0.00 | filing |
| 30 Jun 2020filed 2 Jul 2020 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —44,470 at $0.00 | filing |
| 6 Jun 2019filed 10 Jun 2019 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —21,911 at $0.00 | filing |
| 1 Oct 2018filed 3 Oct 2018 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —10,516 at $0.00 | filing |
News
Critical Analysis: Bionano Genomics (NASDAQ:BNGO) & Personalis (NASDAQ:PSNL)BNGO · tickerreport.com · 24 Oct 2026
0 headlines in the last 90 days name Albert Luderer; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.